Coinfection with Dengue virus (DENV) serotypes 1 and 2 during a dengue outbreak in the state of Paraná, Brazil

Léo Shigueki Sato,Deborah de Castro Moreira,Sonia Kaori Miyamoto,Luciana Dias Ghiraldi Lopes,Dennis Armando Bertolini

DOI: https://doi.org/10.1007/s42770-024-01580-y

2024-12-07

Brazilian Journal of Microbiology

Abstract:Braz J Microbiol . 2024 Dec 5. doi: 10.1007/s42770-024-01580-y. Online ahead of print. NO

microbiology

What problem does this paper attempt to address?

Co-infection between Zika and different Dengue serotypes during DENV outbreak in Brazil

Cássia F Estofolete,Ana C B Terzian,Tatiana E Colombo,Georgia de Freitas Guimarães,Helio C Ferraz Junior,Rafael A da Silva,Gilmar V Greque,Maurício L Nogueira

DOI: https://doi.org/10.1016/j.jiph.2018.09.007

Abstract:Background: The recent introduction of new arboviruses in the Americas, as Zika virus (ZIKV) and Chikungunya virus (CHIKV), increased the risk of outbreaks and arboviral co-infections. Herein, we report twelve cases of co-infection of ZIKV and different DENV serotypes in a city located in the northwest region of São Paulo State, Brazil, which is hyper-endemic to Dengue. Methods: Between January and November 2016, 1254 suspected cases of arboviral infection were available by our surveillance program in São José do Rio Preto. All suspected patients were examined and, when they were arboviral disease-suspectd, had sera separated and viral RNA analyzed by PCR/qPCR assays to determine the diagnosis of DENV 1-4, ZIKV, or CHIKV in the same samples. After the molecular results, twelve patients with ZIKV-DENV coinfection were identified and their clinical and laboratory characteristics were described. Results: The mean between symptoms onset and collected sample of 3 days. DENV-1 was identified in seven co-infected patients and DEN2 in other five. Two patients presented alarm signs of Dengue and no one was hospitalized. Conclusions: The constant presence of co-circulating arboviruses increases the chance of co-infection and demonstrates the importance of the differential diagnosis, especially during periods of arboviral outbreaks. The impact of this co-infection is known individual and collectively.
Simultaneous circulation and coinfection of Dengue clades and serotypes in Southern Brazil

Thales Bermann,Ludmila Fiorenzano Baethgen,Tatiana Schäffer Gregianini,Fernanda Godinho,Regina Bones Barcellos,Amanda Pellenz Ruivo,Milena Bauerman,Taina Machado Selayaran,Franciellen Machado dos Santos,Julio Augusto Schoerer,Érica Bortoli Möllmann,Fernanda Letícia Martiny,Valeska Lizzi Lagranha,Luiz Felipe Valter de Oliveira,Ana Gorini da Veiga,Andreia Carina Turchetto Zolet,Gabriel Luz Wallau,Richard Steiner Salvato

DOI: https://doi.org/10.1101/2024.02.24.581892

2024-02-25

Abstract:Dengue is an arthropod-borne virus with worldwide urban transmission mediated by anthropophilic vectors of the genus . Currently, there is a substantial genotype diversity that belongs to at least four known serotypes. Tropical regions, where several serotypes cocirculate in the population, are hyperendemic, driving multiple outbreaks with variable disease manifestations. Notably, the Dengue virus burden is increasing in subtropical and temperate regions of the globe due to climatic changes associated with new outbreaks in naive and previously unaffected human populations. The introduction and endemic transmission of different clades and serotypes in these regions is highly concerning due to the known and still unknown consequences of Dengue infection on populations with diverse genetic backgrounds. Here, we characterized the coinfection of different Dengue clades and serotypes in Rio Grande do Sul, Brazil’s southernmost and subtropical state, by combining serotype-specific RT-PCR and deep sequencing. We found five coinfected patients in four municipalities where these clades and serotypes circulated simultaneously. Our data suggests that coinfection events account for a minority of total cases, but these findings may reflect the early transmission phases of some Dengue clades. Hence, close monitoring is warranted to evaluate coinfection rates and associated clinical consequences as clade prevalence changes.

Genomics
DENV-2 Outbreak Associated With Cosmopolitan Genotype Emergence in Western Brazilian Amazon

Jessiane Rodrigues Ribeiro,Tárcio Peixoto Roca,Gleense Dos Santos Cartonilho,Ana Maísa Passos-Silva,Hillquias Monteiro Moreira,Karolaine Santos Teixeira,André Luiz Ferreira da Silva,Celina Aparecida Bertoni Lugtenburg,Alcione Oliveira Dos Santos,Juan Miguel Villalobos Salcedo,Valdinete Alves do Nascimento,Victor Costa de Souza,Rosemary Aparecida Roque,Marco Aurélio Krieger,Felipe Gomes Naveca,Rita de Cássia Pontello Rampazzo,Deusilene Souza Vieira

DOI: https://doi.org/10.1177/11779322241251581

2024-05-11

Abstract:Background: Dengue virus (DENV) causes an important disease and directly affects public health, being the arbovirus that presents the highest number of infections and deaths in the Western Brazilian Amazon. This virus is divided into 4 serotypes that have already circulated in the region. Methodology: Molecular characterization of a cohort containing 841 samples collected from febrile patients between 2021 and 2023 was analyzed using a commercial kit to detect the main arboviruses circulating in Brazil: Zika, DENV-1, DENV-2, DENV-3, DENV-4 and, Chikungunya. Subsequently, Sanger sequencing was performed for positive samples. Results: The cohort detected 162 positive samples, 12 for DENV-1 and 150 identified as DENV-2, indicating co-circulation of serotypes. The samples were subjected to sequencing and the analysis of the sequences that obtained good quality revealed that 5 samples belonged to the V genotype of DENV-1 and 46 were characterized as DENV-2 Cosmopolitan genotype-lineage 5. Conclusion: The results allowed us to identify for the first time the Cosmopolitan genotype in Rondônia, Brazilian Western Amazon, and its fast spread dispersion.
Epidemiological and genetic aspects of the largest dengue outbreak recorded in 2015 in Southeastern Brazil

Aline Diniz Cabral,Luana Prado Rolim de Oliveira,Juliana Sá Teles de Oliveira Molina,Andreia Moreira Dos Santos Carmo,Rodrigo Buzinaro Suzuki,Camila Marcondes de Oliveira,Luciamare Perinetti Alves Martins,Carlos Roberto Prudencio,André Eterovic,Márcia Aparecida Sperança

DOI: https://doi.org/10.1590/S1678-9946202163017

2021-03-24

Abstract:Dengue virus, the etiological agent of dengue fever (DF) occurs in four genetically distinct serotypes (DENV1-4), being transmitted by female Aedes mosquitoes. DF incidence is increasing in Brazil, following vector dispersal, proliferation and DENV serotypes introduction, co-circulation and substitution. Medium- and small-sized cities in Sao Paulo State, such as Marilia (Midwest region), have been affected by huge epidemics. To understand the evolution of DENV epidemics in medium-sized cities, in this study a historical data on DENV incidence (2000-2015) in Marilia, was evaluated. Previous studies disclosed regional and specific DF outcomes associated with 2007 outbreak in that city, when co-circulating DENV1 and DENV3 presented different hematological profiles. In this study, characteristics of 2007 DENV epidemics were compared to the epidemiological, hematological and demographic outlines of the major outbreak of DENV1 in Marilia in 2015. DENV1 genetic diversity was assessed through capsid and pre-membrane junction encoding gene (CprM) sequencing. The results revealed circulation of DENV1 serotype from 2007 to 2015, with epidemics occurring every three-years until 2013 and then, increasing yearly. There were significant differences in hematological profiles of DENV1 patients between 2015 and 2007. CprM showed DENV1 genetic variability in 2015, contrasting with the unique sequence pattern in 2007. These results reinforce the regional and temporal characteristics of DENV epidemics that need local public health research to improve care for people and to limit the spread of new serotypes/genotypes to uninfected areas.
Double Trouble: Dengue Followed by COVID-19 Infection Acquired in Two Different Regions: A Doctor’s Case Report and Spatial Distribution of Cases in Presidente Prudente, São Paulo, Brazil

Sérgio Munhoz Pereira,Charlene Troiani do Nascimento,Rodrigo Sala Ferro,Edilson Ferreira Flores,Elaine Aparecida Maldonado Bertacco,Elivelton da Silva Fonseca,Luiz Euribel Prestes-Carneiro

DOI: https://doi.org/10.3390/tropicalmed6030156

2021-08-25

Tropical Medicine and Infectious Disease

Abstract:Co-epidemics of COVID-19 and dengue in dengue-endemic countries represent a serious public health concern. In Brazil, São Paulo state ranks first for cases and deaths from COVID-19, and dengue is endemic in most regions of the country. In 2020, an outbreak of dengue occurred in western São Paulo. We determined the spatiotemporal distribution of dengue in the context of COVID-19 cases in Presidente Prudente, a mid-sized city in western São Paulo. To illustrate the burden of both infections, a case report of a doctor and his family, infected with dengue and COVID-19, is presented. There were three clusters of dengue and COVID-19 in the periphery. A dengue cluster was found in a region where there were no corresponding COVID-19 cases. Meanwhile, there were COVID-19 clusters where dengue activity was lower. In 2020, the COVID-19 epidemic emerged when dengue reached its seasonal peak, resulting in a simultaneous outbreak of both diseases. Lower rates of dengue were found in the city compared with 2019, and the fear of patients with mild dengue symptoms about remaining in hospital and acquiring COVID-19 infection may be the main cause. Simultaneous spatial clusters of dengue and COVID-19 in environmentally and socioeconomically vulnerable areas can guide public health authorities in intensive interventions to improve clinical diagnosis, epidemiological surveillance, and management of both diseases. The patient and his family were first infected with dengue and he then carried COVID-19 to his family, reinforcing the risk of health care workers spreading the virus to the community. We highlight the epidemiological significance of presenting a case report and spatial analysis of COVID-19 in the same study in the context of a dengue outbreak.
Clinical and biochemical parameters of COVID-19 patients with prior or active dengue fever

Isabella Márcia Soares Nogueira Teotônio,Juliana Lott de Carvalho,Luiz Cláudio Castro,Nadjar Nitz,Luciana Hagström,Geraldo Gonçalves Rios,Maria de Fátima Rodrigues de Oliveira,Bruno Stéfano Lima Dallago,Mariana Hecht

DOI: https://doi.org/10.1016/j.actatropica.2020.105782

Abstract:Originated in Wuhan, China, the coronavirus 19 disease (COVID-19) has quickly spread worldwide, reaching countries that already faced other endemics and epidemics. In Brazil, such a concerning situation includes arboviruses, among which the dengue virus stands out. Here, we determined the rate of SARS-CoV-2/dengue virus co-infection in a total of 178 patients with COVID-19 symtoms admitted into a large public hospital of the Federal District of Brazil. Furthermore, we evaluated whether prior or active dengue virus infection influenced hematological, biochemical, and clinical parameters of such patients. One hundred and twelve (63%) individuals tested positive for COVID-19, of which 43 (38.4%) were co-infected with dengue virus, and 50 (44.6%) had antibodies indicative of previous dengue infection. Co-infected patients showed lower numbers of circulating lymphocytes and monocytes, higher glucose rates, and a worse pulmonary condition. Of note, prior infections with dengue virus did not influence clinical parameters, but active dengue fever resulted in higher hospitalization rate. In conclusion, amid the current complex epidemiological scenario in Brazil, our data support the notion that SARS-CoV-2 and dengue co-infection affects an important percentage of COVID-19 patients and leads to worse clinical parameters, requiring greater attention from health authorities.
Dengue epidemics in two distinct periods reveal distinct epidemiological, laboratorial and clinical aspects in a same scenario: analysis of the 2010 and 2013 epidemics in Mato Grosso do Sul, Brazil

Nieli Rodrigues da Costa Faria,Victor Edgar Fiestas Solorzano,Rita Maria Ribeiro Nogueira,Thaís Chouin-Carneiro,Priscila Conrado Guerra Nunes,Jaqueline Bastos Santos Simões,Fernanda de Bruycker Nogueira,Monique da Rocha Queiroz Lima,Luzia Maria de Oliveira Pinto,Claire Fernandes Kubelka,Rivaldo Venâncio da Cunha,Elzinandes Leal de Azeredo,Flavia Barreto dos Santos

DOI: https://doi.org/10.1093/trstmh/trw013

Abstract:Background: Dengue is a major problem in Brazil. Epidemiological and clinical aspects were characterized in patients from two epidemics which occurred in Mato Grosso do Sul, Brazil. Methods: Dengue cases were classified according to the 2009 WHO criteria, tested by serological and molecular biology tests and analysed for nonstructural protein 1 (NS1) antigenemia. Results: Dengue was confirmed in 78.7% (48/61) and 75.6% (118/156) of the cases studied in 2010 and 2013, respectively. DENV-1 and DENV-2 were the serotypes involved in the 2010 epidemic and DENV-4 in the 2013 one. Most of the cases were classified as dengue without warning; however, severe dengue was observed in 18.7% (9/48) of the cases in 2010 and less observed in DENV-4 cases. NS1 levels were higher in patients with dengue with warning signs and severe dengue in 2010. Circulating aspartate aminotransferase (AST) and alanine transferase (ALT) were altered in all groups, independently of the infecting serotype or epidemic. Patients with DENV-1 and DENV-2 presented significant lower monocyte counts when compared to patients with DENV-4. An inverse correlation was found between platelet count, leucocytes, monocytes and NS1 levels. Conclusions: Epidemics caused by the prevalence of distinct DENV serotypes had different impacts and clinical characteristics in a same scenario and, despite the occurrence of secondary infections, the DENV-4 emergence was not associated with severe cases.
Dengue and SARS-CoV-2 co-circulation and overlapping infections in hospitalized patients

Thayza M. I. L. Santos,Alice F. Versiani,Guilherme R. F. Campos,Marilia M. Moraes,Maisa C. P. Parra,Natalia F. B. Mistrao,Andreia F. Negri,Flavia F. Bagno,Marina G. Galves,Camila M. Moreno,Flavio G. Da Fonseca,Cassia F. Estofolete,Nikos Vasilakis,Mauricio L. Nogueira

DOI: https://doi.org/10.3389/fcimb.2024.1429309

IF: 6.073

2024-11-09

Frontiers in Cellular and Infection Microbiology

Abstract:Since its emergence in 2019, coronavirus disease (COVID-19) has spread worldwide and consumed public health resources. However, the world still has to address the burdens of other infectious diseases that continue to thrive. Countries in the tropics and neotropics, including Brazil, are affected by annual, cyclic dengue epidemics. Little is known about the impact of subsequent infections between DENV and SARS-CoV-2. Our study was performed on 400 serum samples collected from laboratory-confirmed COVID-19 patients between January and June 2021, months historically known for DENV outbreaks in Brazil. The samples were tested by serology and molecular assays for the presence of DENV and other arboviruses. While no DENV PCR results were detected, 6% were DENV IgM-positive, and 0.25% were DENV NS1-positive according to ELISA. IgM antibodies were isolated by chromatography, and 62.5% of the samples were positive for neutralizing antibodies (FRNT 80 ) against DENV IgM, suggesting a recent infection. We also observed increased IL-10, TNF-α, and IL-1β levels in patients with overlapping SARS-CoV-2/DENV infections. Intriguingly, diabetes was the only relevant comorbidity (p=0.046). High rates of hospitalization (94.9%) and mortality (50%) were found, with a significant increase in invasive mechanical ventilatory support (86.96%) in SARS-CoV-2/DENV- infected patients, suggesting an impact on patient clinical outcomes. When analyzing previous exposure to DENV, secondary dengue patients infected with SARS-CoV-2 more frequently presented with dyspnea and respiratory distress, longer hospital and intensive care unit (ICU) stays (4 and 20.29 days, respectively) and a higher mortality rate (60%). However, a greater proportion of patients with primary DENV infection had fever and cough than patients with secondary dengue (87.50% vs. 33.33%, p=0.027 for fever). Our data demonstrate that differentiating between the two diseases is a great concern for tropical countries and should be explored to improve patient management.

immunology,microbiology
Clinical, Molecular, and Epidemiological Analysis of Dengue Cases during a Major Outbreak in the Midwest Region of Minas Gerais, Brazil

Juliana Cristina Duarte Braga,Leandro César da Silva,Jacqueline Domingues Tibúrcio,Mirna de Abreu e Silva,Lailah Horácio Sales Pereira,Karina Rocha Dutra,Jaqueline Maria Siqueira Ferreira,Débora de Oliveira Lopes,Luciana Lara dos Santos

DOI: https://doi.org/10.1155/2014/276912

2014-01-01

Journal of Tropical Medicine

Abstract:This study aims to perform the first molecular and clinical-epidemiological analysis of dengue cases in Divinopolis, MG, Brazil. Data from 4,110 cases of dengue were accessed and 190 clinical samples were collected for molecular analyses. In this study, 2.7% of the men and 3.0% of the women were admitted to hospital. There was no association between gender and hospital admission. The symptoms observed in this study are according to the Health Ministry, but fever was present in 82.2% and not in 100% of cases. The chance of hospital admission was 1.55 higher in patients with any kind of bleeding (334) and 2.4% of individuals without bleeding were also hospitalized due to other warning signs. In the molecular analyses, 23% of the samples were positive for DENV. DENV-2 and DENV-3 were identified in 2010, DENV-3 in 2011, DENV-1 in 2012, and DENV-1 and DENV-4 in 2013. DENV detection was possible in samples with only one day of symptoms. This first report of dengue data in Divinópolis provided more insight into the viral types and effects of disease in the city, confirming the need for caution in assessing cases of suspected dengue and for revision of the criteria proposed by the Health Ministry to classify cases of the disease.

public, environmental & occupational health,tropical medicine
Simultaneous detection of arboviruses by a multiplex RT-qPCR assay in Tocantins, a northern state of Brazil

Matheus Martins Daude,Erika Regina Manuli,Geovana Maria Pereira,Alfredo Ramon Alfonso Cavalcante Junior,Ueric José Borges de Souza,Gessi Carvalho de Araujo,Flávio Augusto de Pádua Milagres,Ester Cerdeira Sabino,Horllys Gomes Barreto

DOI: https://doi.org/10.1016/j.bjid.2024.103855

Abstract:In Brazil, Dengue, Zika and Chikungunya viruses constitute a major threat to the public health system. Simultaneous circulation of these arboviruses occurs in many regions of the world due to the expansion of transmission vectors. The infection by these arboviruses triggers similar symptoms during their acute phase. However, in some cases, severe symptoms may occur, leading to different types of disabilities and even death. In this context, considering the similarity of the symptoms, the problems caused by the infection of these arboviruses, and the increasing risk of coinfection in humans, the differential diagnosis of these infections is essential for clinical management and epidemiological investigation. Thus, this study aimed to identify, through diagnosis via Quantitative Polymerase Chain Reaction with Reverse Transcription, arbovirus coinfection in patients from the Tocantins state (Northern Brazil). A total of 495 samples were analyzed, three from which were determined to be a coinfection of Dengue and Chikungunya viruses. The data obtained here indicate the co-circulation and coinfection by Dengue and Chikungunya viruses in the Tocantins state. These results highlight the importance of monitoring the circulation of these arboviruses for the development of health actions that aim their prevention and combat, as well as their clinical and therapeutic management.
Viral coinfection in hospitalized patients during the COVID-19 pandemic in Southern Brazil: a retrospective cohort study

Jaqueline Rhoden,Andressa Taíz Hoffmann,Janaína Franciele Stein,Bruna Seixas da Rocha,Vinícius Monteagudo de Barros,Eduardo Viegas da Silva,Juliane Deise Fleck,Caroline Rigotto

DOI: https://doi.org/10.1186/s12931-024-02708-2

IF: 5.8

2024-02-08

Respiratory Research

Abstract:Since the worldwide spread of SARS-CoV-2, different strategies have been followed to combat the pandemic and limit virus transmission. In the meantime, other respiratory viruses continued to circulate, though at decreased rates.

respiratory system
COVID-19 and dengue coinfection in Latin America: A systematic review

Darwin A León-Figueroa,Sebastian Abanto-Urbano,Mely Olarte-Durand,Janeth N Nuñez-Lupaca,Joshuan J Barboza,D Katterine Bonilla-Aldana,Robinson A Yrene-Cubas,Alfonso J Rodriguez-Morales

DOI: https://doi.org/10.1016/j.nmni.2022.101041

Abstract:Introduction: Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has spread globally, becoming a long-lasting pandemic. Dengue is the most common arboviral disease in tropical and subtropical regions worldwide. COVID-19 and dengue coinfections have been reported, associated with worse outcomes with significant morbidity and mortality. Therefore, this study aims to determine the epidemiological situation of COVID-19 and dengue coinfection in Latin America. Methods: A systematic literature review was performed using PubMed, Scopus, Embase, Web of Science, LILACS, and BVS databases from January 1, 2020, to September 4, 2021. The key search terms used were "dengue" and "COVID-19". Results: Nineteen published articles were included. The studies were case reports with a detailed description of the coinfection's clinical, laboratory, diagnostic, and treatment features. Conclusion: Coinfection with SARS-CoV-2 and dengue virus is associated with worse outcomes with significant morbidity and mortality. The similar clinical and laboratory features of each infection are a challenge in accurately diagnosing and treating cases. Establishing an early diagnosis could be the answer to reducing the estimated significant burden of these conditions.
Characterization of Dengue Virus 4 Cases in Paraguay, 2019–2020

Alejandra Rojas,John Shen,Fátima Cardozo,Cynthia Bernal,Oliver Caballero,Sara Ping,Autum Key,Ali Haider,Yvalena de Guillén,Patricia Langjahr,Maria Eugenia Acosta,Laura Aria,Laura Mendoza,Malvina Páez,Marta Von-Horoch,Patricia Luraschi,Sandra Cabral,María Cecilia Sánchez,Aurelia Torres,Benjamin A. Pinsky,Anne Piantadosi,Jesse J. Waggoner

DOI: https://doi.org/10.3390/v16020181

2024-01-26

Viruses

Abstract:In 2019–2020, dengue virus (DENV) type 4 emerged to cause the largest DENV outbreak in Paraguay's history. This study sought to characterize dengue relative to other acute illness cases and use phylogenetic analysis to understand the outbreak's origin. Individuals with an acute illness (≤7 days) were enrolled and tested for DENV nonstructural protein 1 (NS1) and viral RNA by real-time RT-PCR. Near-complete genome sequences were obtained from 62 DENV-4 positive samples. From January 2019 to March 2020, 799 participants were enrolled: 253 dengue (14 severe dengue, 5.5%) and 546 other acute illness cases. DENV-4 was detected in 238 dengue cases (94.1%). NS1 detection by rapid test was 52.5% sensitive (53/101) and 96.5% specific (387/401) for dengue compared to rRT-PCR. DENV-4 sequences were grouped into two clades within genotype II. No clustering was observed based on dengue severity, location, or date. Sequences obtained here were most closely related to 2018 DENV-4 sequences from Paraguay, followed by a 2013 sequence from southern Brazil. DENV-4 can result in large outbreaks, including severe cases, and is poorly detected with available rapid diagnostics. Outbreak strains seem to have been circulating in Paraguay and Brazil prior to 2018, highlighting the importance of sustained DENV genomic surveillance.

virology
Resurgence of Dengue Virus Serotype 3 in Minas Gerais, Brazil: A Case Report

Talita Adelino,Maurício Lima,Natália R. Guimarães,Joilson Xavier,Vagner Fonseca,Luiz Marcelo R. Tomé,Maira Alves Pereira,Vanessa Ferreira Machado,Luiz Carlos Junior Alcantara,Felipe C. de Melo Iani,Marta Giovanetti

DOI: https://doi.org/10.3390/pathogens13030202

IF: 3.7

2024-02-25

Pathogens

Abstract:This report provides a detailed overview of the resurgence of DENV-3 in the state of Minas Gerais, Brazil, which is a concerning scenario in the context of dengue, a mosquito-borne viral disease. Historically, Brazil has grappled with dengue epidemics caused primarily by the DENV-1 and DENV-2 serotypes. However, in 2023, a significant shift in this pattern was observed as DENV-3 made a notable resurgence. This resurgence was characterized by the increase in DENV-3 cases within the country and the region of the Americas. Given the absence of sustained DENV-3 circulation in Brazil in previous years, this situation poses a significant risk, making the population highly susceptible to a potential novel epidemic. In November 2023, a 31-year-old male patient in Belo Horizonte exhibited symptoms of acute febrile syndrome. Multiplex RT-qPCR using the Kit Molecular ZC D-Tipagem confirmed DENV-3 infection, suggesting a likely autochthonous case, as the patient reported no travel history. To promptly assess this resurgence, we applied the nanopore sequencing technology. This allowed for the rapid characterization of the initial DENV-3 case isolated in Minas Gerais in 2023, representing a 13-year interval since the serotype's previous documented circulation in that state. This case report underscores the critical importance of proactive monitoring and the swift implementation of targeted control strategies to address the evolving dynamics of dengue, with a specific emphasis on the resurgence of DENV-3 in the state.

microbiology
Phylogenetics, Epidemiology and Temporal Patterns of Dengue Virus in Araraquara, São Paulo State

Caio Santos de Souza,Giovana Santos Caleiro,Ingra Morales Claro,Jaqueline Goes de Jesus,Thaís Moura Coletti,Camila Alves Maia da Silva,Ângela Aparecida Costa,Marta Inenami,Andreia C. Ribeiro,Alvina Clara Felix,Anderson Vicente de Paula,Walter M. Figueiredo,Expedito José de Albuquerque Luna,Ester C. Sabino,Camila M. Romano

DOI: https://doi.org/10.3390/v16020274

2024-02-10

Viruses

Abstract:Dengue virus (DENV) is a prominent arbovirus with global spread, causing approximately 390 million infections each year. In Brazil, yearly epidemics follow a well-documented pattern of serotype replacement every three to four years on average. Araraquara, located in the state of São Paulo, has faced significant impacts from DENV epidemics since the emergence of DENV-1 in 2010. The municipality then transitioned from low to moderate endemicity in less than 10 years. Yet, there remains an insufficient understanding of virus circulation dynamics, particularly concerning DENV-1, in the region, as well as the genetic characteristics of the virus. To address this, we sequenced 37 complete or partial DENV-1 genomes sampled from 2015 to 2022 in Araraquara. Then, using also Brazilian and worldwide DENV-1 sequences we reconstructed the evolutionary history of DENV-1 in Araraquara and estimated the time to the most recent common ancestor (tMRCA) for serotype 1, for genotype V and its main lineages. Within the last ten years, there have been at least three introductions of genotype V in Araraquara, distributed in two main lineages (L Ia and L Ib, and L II). The tMRCA for the first sampled lineage (2015/2016 epidemics) was approximately 15 years ago (in 2008). Crucially, our analysis challenges existing assumptions regarding the emergence time of the DENV-1 genotypes, suggesting that genotype V might have diverged more recently than previously described. The presence of the two lineages of genotype V in the municipality might have contributed to the extended persistence of DENV-1 in the region.

virology
Coinfection with Canine Distemper Virus and Yellow Fever Virus in a Neotropical Primate in Brazil

Maria Angélica Monteiro de Mello Mares-Guia,Marina Carvalho Furtado,Flávia Löwen Levy Chalhoub,Maria Dulce Portugal,Janice Mery Chicarino de Oliveira Coelho,Ana Maria Bispo de Filippis,Felipe Gomes Naveca

DOI: https://doi.org/10.3390/v16111670

2024-10-26

Viruses

Abstract:We describe a natural coinfection with canine distemper virus (CDV) and yellow fever virus in a free-ranging neotropical primate of the genus Callithrix, found dead in the northeastern region of Brazil. The laboratory diagnosis included histopathology, immunohistochemistry, rRT-PCR, and phylogenetic analyses. The CDV sequences from this primate in Brazil represent a divergent lineage in Rio Grande do Norte, closely related to genotypes EU1/South America 1 and South America 2. To our knowledge, this is the first report of natural coinfection by CDV and yellow fever virus in a neotropical primate, underscoring the need to further investigate the circulation of this virus in Brazilian nonhuman primates and its potential implications for wildlife conservation.

virology
Dengue outbreaks in Brazil and Latin America: the new and continuing challenges

Nathália Mariana Santos Sansone,Matheus Negri Boschiero,Fernando Augusto Lima Marson

DOI: https://doi.org/10.1016/j.ijid.2024.107192

Abstract:Objectives: To compare the number of suspected cases, severe cases, and deaths of dengue in 2023 and 2024 in Brazil and Latin America; and to describe its epidemiological profile. Design: Observational study. Methods: The data regarding dengue was retrieved from the Brazilian Ministry of Health website. The Chi-square test was used to compare the proportion of dengue cases in 2023 and 2024 according to gender, race, and age range. The odds ratio and the 95% confidence intervals were used to describe the data. The Spearman correlation test was used to compare the number of suspected cases, severe cases, and deaths of dengue with the number of distributed vaccines against dengue. Results: Dengue is one of the most common zoonoses in Latin America. In 2023, Brazil registered a total of 1,658,814 suspected cases of dengue with 1094 deaths. For 2024, a total of 1,978,372 suspected cases of dengue were reported only until the 11th epidemiological week, with 656 deaths. When comparing dengue cases reported in 2024 and 2023, there is an increase in suspected cases, with 20% more cases reported during the first 11 epidemiological weeks of 2024 than in the entire 52 epidemiological weeks of 2023. At the same time, in 2024, the Pan American Health Organization reported suspected cases in 20 Latin American countries, with 3073 cases of severe dengue and 1187 deaths. In Brazil, a different racial profile for dengue was described since Black people [OR = 1.56 (95% CI = 1.54-1.57)], Mixed individuals [OR = 1.36 (95% CI = 1.35-1.37), and Indigenous peoples [OR = 1.77 (95% CI = 1.70-1.85)] were more likely to be suspected cases of dengue in 2024 compared to 2023. Also, a positive correlation between the distributed vaccines with deaths due to dengue and the number of severe cases was described. Conclusion: Brazil was responsible for more than 50% of suspected cases and deaths from dengue compared to the other Latin American countries in 2024. Furthermore, there is a different racial profile for dengue in Brazil, as Black people, Mixed individuals, and Indigenous peoples were more likely to be suspected cases of dengue in 2024 compared to 2023.
Exploring the Chikungunya virus landscape in a dengue-endemic Brazilian area

Debora Glenda Lima de La Roque,Elaine Vieira Santos,Lucca Rocha Policastro,Péricles Natan Mendes da Costa,Mariane Evaristo,Aparecida Yulie Yamamoto,Denise Bergamaschi Giomo,Paula Marilia Afonso Torres,Danielle Cristina Dacanal Gentil,Elaine Cristina Manini Minto,Svetoslav Nanev Slavov,Vagner Fonseca,Claudia Renata dos Santos Barros,Antonio Jorge Martins,Rodrigo Tocantins Calado,Luzia Márcia Romanholi Passos,Maria Carolina Elias,Sandra Coccuzzo Sampaio,Marta Giovanetti,Dimas Tadeu Covas,Luiz Carlos Júnior Alcântara,Simone Kashima

DOI: https://doi.org/10.1016/j.jiph.2024.04.026

IF: 7.537

2024-06-01

Journal of Infection and Public Health

Abstract:We aimed to describe the landscape, including molecular, epidemiological, and clinical aspects of CHIKV infections in the Ribeirao Preto region, an area endemic to dengue. We randomly screened 3744 plasma samples that had undergone DENV diagnosis to evaluate CHIKV-RNA using an in-house RT-PCR assay. Positive samples were followed clinically, and RNA samples were submitted to whole genome sequencing. Seventeen cases (0.5 %) were positive for CHIKV-RNA despite being negative for DENV-RNA. Notably, half of the patients experienced prolonged arthralgia lasting more than 90 days. Compared with the healthy control group, leukopenia and thrombocytopenia were observed in all CHIKV-positive individuals with statistically significant P values (P < 0.0001 and P = 0.0003, respectively). The genomic analysis revealed that the CHIKV strains being studied are classified within the East-Central-South-African (ECSA) genotype. This analysis identified new mutations, E1: K211E and E2: V264A, while the previously known mutation E1: A226V was not detected among these strains. This study highlights the need for epidemiological surveillance and preparedness for potential CHIKV epidemics in Brazil, particularly where other arboviruses co-circulate.

infectious diseases,public, environmental & occupational health
High Frequencies of kdr Mutation and Chikungunya Infection in Aedes aegypti Population from Minas Gerais, Brazil

Pedro Augusto Almeida-Souza,Cirilo Henrique de Oliveira,Luiz Paulo Brito,Thaynara de Jesus Teixeira,Iago Alves Celestino,Gabriele Barbosa Penha,Ronaldo Medeiros dos Santos,Wexley Miranda Mendes,Bergmann Morais Ribeiro,Fabrício Souza Campos,Paulo Michel Roehe,Natalia Rocha Guimarães,Felipe C. M. Iani,Ademir Jesus Martins,Filipe Vieira Santos de Abreu

DOI: https://doi.org/10.3390/pathogens13060457

IF: 3.7

2024-05-28

Pathogens

Abstract:The Chikungunya virus (CHIKV) presents global health challenges, with Brazil experiencing outbreaks since its introduction in 2014. In 2023, following a CHIKV outbreak in Minas Gerais (MG), social media was used to optimize an entomological survey aimed at identifying vectors and viral lineages and assessing insecticide resistance. Following Instagram posts, residents with suspected CHIKV infection were able to schedule mosquito aspirations. In total, 421 mosquitoes (165 Aedes aegypti and 256 Culex quinquefasciatus) were captured from 40 households in Salinas city (MG) and tested for the Dengue, Zika, and Chikungunya viruses through RT-qPCR. Twelve of 57 pools (10 Ae. aegypti and two Cx. quinquefasciatus) tested positive for CHIKV RNA. Viral RNA was also detected in the heads of nine Ae. aegypti, indicating viral dissemination but not in Cx. quinquefasciatus. Genome sequencing yielded the first near-complete genome from the 2023 outbreak, unveiling that the CHIKV strain belonged to the East/Central/South African (ECSA) genotype. Additionally, genetic analyses revealed high frequencies of kdr alleles, including in CHIKV-infected mosquitoes, suggesting resistance to pyrethroid insecticides in this Ae. aegypti population. Social media was important for guiding mosquito-capture efforts in CHIKV transmission hotspots, thus optimizing the opportunity for viral detection. These findings emphasize the urgent need for innovative vector studies and control strategies, as well as interdisciplinary approaches in public health interventions.

microbiology
Analysis of Dengue and SARS‐CoV‐2 Coinfection in a Tertiary Care Hospital: A Retrospective Study

Vinayaka Korishetty,Pooja Rao,Suchitra Shenoy,Udayalaxmi Jeppu,Keerthiraj B.

DOI: https://doi.org/10.1155/2024/6788850

2024-09-20

Journal of Tropical Medicine

Abstract:Introduction. Coinfection of dengue virus and SARS‐CoV‐2 infections in dengue‐endemic areas is a significant public health concern. Coinfections can result in severe illness. Hence, this study determines the incidence of dengue and COVID‐19 coinfection for a better understanding of the clinical presentation, laboratory parameters, and outcomes including mortality. Methods. The patients admitted to two tertiary hospitals with RT PCR‐proven COVID‐19 infection and dengue positive by NS1 rapid antigen or IgM dengue ELISA for two years between January 2020 and December 2022 were considered. Clinical data were retrieved from medical records including the laboratory findings and outcomes of these patients. The categorical data were analyzed in the form of frequency and proportion. The quantitative data were analyzed in the form of mean, median, and proportion. Results. Out of 2301 confirmed dengue samples and 3718 confirmed COVID‐19 samples, there were 14 cases of coinfection with the presence of COVID‐19 and dengue infection at the same time. ICU admission of 14.2% and mean hospital stay of 7 days were noted. Mainly the symptoms reported were fever at 92.9%, myalgia at 35.7%, and headache, vomiting, and cough at 28.6%. The laboratory findings were elevated lactate dehydrogenase and C‐reactive protein in 100% of patients, elevated ferritin in 92.9%, thrombocytopenia in 71.4%, elevated AST and ALT in 71.4%, and elevated D‐dimer in 57.1% of patients. There was no effect on morbidity and mortality seen among coinfection. Conclusion. COVID‐19 and dengue share similar clinical features and laboratory findings. Diagnosis of one disease cannot rule out the presence of other infections. There might be chances of misdiagnosis or missed diagnosis. Hence, it is important to stress about early detection using specific methods and confirmation of disease with timely management, as it is a potentially new dimension for public health concern and management.

public, environmental & occupational health,tropical medicine

Coinfection with Dengue virus (DENV) serotypes 1 and 2 during a dengue outbreak in the state of Paraná, Brazil

Co-infection between Zika and different Dengue serotypes during DENV outbreak in Brazil

Simultaneous circulation and coinfection of Dengue clades and serotypes in Southern Brazil

DENV-2 Outbreak Associated With Cosmopolitan Genotype Emergence in Western Brazilian Amazon

Epidemiological and genetic aspects of the largest dengue outbreak recorded in 2015 in Southeastern Brazil

Double Trouble: Dengue Followed by COVID-19 Infection Acquired in Two Different Regions: A Doctor’s Case Report and Spatial Distribution of Cases in Presidente Prudente, São Paulo, Brazil

Clinical and biochemical parameters of COVID-19 patients with prior or active dengue fever

Dengue epidemics in two distinct periods reveal distinct epidemiological, laboratorial and clinical aspects in a same scenario: analysis of the 2010 and 2013 epidemics in Mato Grosso do Sul, Brazil

Dengue and SARS-CoV-2 co-circulation and overlapping infections in hospitalized patients

Clinical, Molecular, and Epidemiological Analysis of Dengue Cases during a Major Outbreak in the Midwest Region of Minas Gerais, Brazil

Simultaneous detection of arboviruses by a multiplex RT-qPCR assay in Tocantins, a northern state of Brazil

Viral coinfection in hospitalized patients during the COVID-19 pandemic in Southern Brazil: a retrospective cohort study

COVID-19 and dengue coinfection in Latin America: A systematic review

Characterization of Dengue Virus 4 Cases in Paraguay, 2019–2020

Resurgence of Dengue Virus Serotype 3 in Minas Gerais, Brazil: A Case Report

Phylogenetics, Epidemiology and Temporal Patterns of Dengue Virus in Araraquara, São Paulo State

Coinfection with Canine Distemper Virus and Yellow Fever Virus in a Neotropical Primate in Brazil

Dengue outbreaks in Brazil and Latin America: the new and continuing challenges

Exploring the Chikungunya virus landscape in a dengue-endemic Brazilian area

High Frequencies of kdr Mutation and Chikungunya Infection in Aedes aegypti Population from Minas Gerais, Brazil

Analysis of Dengue and SARS‐CoV‐2 Coinfection in a Tertiary Care Hospital: A Retrospective Study